(Q45858623)

17 December 2017

title

Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD. (English)

1 reference

17 December 2017

author name string

McClorey G

1

1 reference

17 December 2017

Moulton HM

2

1 reference

17 December 2017

Iversen PL

3

1 reference

17 December 2017

Fletcher S

4

1 reference

17 December 2017

Wilton SD

5

1 reference

17 December 2017

publication date

25 May 2006

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

13

1 reference

17 December 2017

issue

19

1 reference

17 December 2017

page(s)

1373-1381

1 reference

17 December 2017

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302800

Longterm noninvasive ventilation in children and adolescents with neuromuscular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302800

Duchenne muscular dystrophy and steroids: pharmacologic treatment in the absence of effective gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302800

Becker muscular dystrophy with onset after 60 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302800

Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302800

Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302800

Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302800

Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more sense

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302800

Use of the dog model for Duchenne muscular dystrophy in gene therapy trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302800

Molecular mechanisms of action of antisense drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302800

Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302800

Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302800

Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302800

An explanation for the constitutive exon 9 cassette splicing of the DMD gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302800

ESEfinder: A web resource to identify exonic splicing enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302800

Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302800

Mfold web server for nucleic acid folding and hybridization prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302800

Analysis of the RNA-recognition motif and RS and RGG domains: conservation in metazoan pre-mRNA splicing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302800

Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302800

Cationic lipid polymerization as a novel approach for constructing new DNA delivery agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302800

Advances in Duchenne muscular dystrophy gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302800

The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302800

21 January 2018

The muscular dystrophies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302800

inferred from DOI database lookup

7 January 2021

based on heuristic

An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302800

inferred from DOI database lookup

7 January 2021

based on heuristic

Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302800

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3302800

1 reference

17 December 2017

Dimensions Publication ID

1005023644

0 references

1 reference

17 December 2017